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Abstract 
Pre-implantation genetic screening (PGS) with trophectoderm biopsy 
is an extremely powerful technique for the determination of embryos with a 
high implantation potential. Patients with cryopreserved embryos seeking 
PGS have had limited access to this treatment due to the need to thaw, biopsy, 
and refreeze these embryos. This is especially true for patients with embryos 
cryopreserved by the slow freeze technique due to the low survival rate after 
thawing. In this case report, we describe the application of refreezing with the 
vitrification technique to embryos thawed with the slow technique and 
biopsied for PGS. The patient had a total of 8 blastocysts thawed, biopsied, 
and refrozen with vitrification. Next Generation Sequencing (NGS) of these 
embryos revealed that 4 blastocysts were euploid. The patients achieved a 
pregnancy on the the first frozen embryo transfer procedure that terminated 
after 11 days. The second frozen embryo transfer procedure resulted in the 
live birth of a 3800g boy, demonstrating that thaw, biopsy, and refreeze are 
applicable to human reproduction even in cases where embryos have been 
cryopreserved by the slow technique. 
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refreezing human embryos, vitrification 
 
Introduction 
Pre-implantation Genetic Screening (PGS) with analysis of the entire 
chromosome content within human embryos offers patients the possibility of 
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testing developing embryos for chromosome normality and a reliable method 
for selecting embryos for transfer (Harper, 2017). Results suggest PGS is a 
cost-effective procedure and decreases the time to pregnancy in patients over 
37 years old (Collins et al., 2017).  
Until recently, the principle technique for whole genome screening 
was array Comparative Genome Hybridisation (aCGH) (Harper, 2017). This 
technique produced results in 24 hours and allowed embryo transfer on the 
same cycle as embryo biopsy. However, a limitation of the technique included 
the necessity to perform biopsy on day 3 (with the removal of a single cell of 
the embryo).  This caused high levels of stress for patients since results were 
obtained 1-2 hours before the embryo transfer procedure was scheduled with 
no guarantee that the embryo transfer procedure would actually take place. 
Next Generation Sequencing (NGS) offers a low-cost, high-resolution 
method for PGS of human embryos and is considered a major breakthrough in 
the field of human embryology (Harper, 2017). However, the extended 
timeframe for NGS results (2-3 weeks) does preclude embryo transfer in the 
same cycle as embryo testing. Therefore embryo cryopreservation techniques 
are required.  
Embryo cryopreservation is an established procedure since 1983 for 
use in human reproduction (Trounson and Mohr, 1983). Traditionally, the 
cryopreservation of human embryos was through the slow method where 
cooling occurred at 1°C per minute, preventing extensive intracellular 
crystallization (Rienzi et al., 2017). More recently, a high efficiency technique 
of embryo cryopreservation, termed vitrification, has been developed (Yokota 
et al., 2000). The efficiency of embryo survival after slow freezing compared 
to vitrification is known to be significantly lower (49.7% versus 88.2%, 
Fernandez-Gallardo et al., 2017, Rienzi et al., 2017), and the time to 
resumption of mitosis is delayed by up to 6 hours after slow freezing 
(Fernandez-Gallardo et al., 2017).  
Patients wishing to have PGS with NGS on cryopreserved embryos are 
currently limited from accessing this technique due to the requirement of 
refreezing embryos. Embryo refreezing with the slow freeze technique appears 
not to be generally practical due to the low survival rate after thaw (Fernandez-
Gallardo et al., 2017; Rienzi et al., 2017). The vitrification of human embryos 
may alleviate this problem due to the reliability of this technique. Few reports 
have explored the use of refreezing of embryos in assisted reproduction.  Mice 
embryos have been shown to tolerate refreezing, even after embryo biopsy 
(Snabes et al., 1993; Vitale et al., 1997). Mice embryos did survive the process 
although the authors reported several negative effects such as lower cell 
numbers at the blastocyst stage (Vitale et al., 1997). Human embryo refreezing 
has been attempted (Smith et al., 2005, Farhat et al., 2001, Kumsako et al., 
2009, Ludwig et al., 1999). Human refrozen embryos have also been 
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transferred to patients with successful outcomes (Farhat et al., 2001, Safari et 
al., 2016). Despite this, refreezing of human embryos is not a widely used 
procedure in the IVF lab at the present time. 
In this case report, we describe the use of vitrification for the refreezing 
of embryos previously frozen with the slow technique. This report 
demonstrates that slow-thawed and biopsied embryos can be refrozen with 
vitrification with no loss of potential, and ongoing clinical pregnancies can be 
obtained with this technique. The data demonstrate that patients with embryos 
cryopreserved by the slow method should not be excluded from NGS 
procedures for this reason alone. 
 
Case Report 
The patients in the present report had a history of trying to conceive 
for 4 years. The female patient was 36 years old at the time of treatment, and 
the male was 41 years old. The couple was diagnosed with idiopathic 
(unexplained) infertility and had completed one long protocol cycle of IVF at 
a different treatment unit. In this unit, she had 29 eggs collected, of which 20 
were mature and 18 fertilised. This resulted in 11 blastocysts, of which 1 
embryo was transferred fresh and 10 embryos were frozen by the slow method 
(Edgar et al., 2017). The fresh embryo transfer resulted in a pregnancy which 
ended in a miscarriage at 10 weeks of gestation. The couple subsequently 
attempted 2 further cycles of single embryo transfer (SET) at the same centre 
without success. The couple transferred their remaining 8 frozen embryos to 
CREATE Fertility for analysis with PGS using NGS. The 8 embryos were 
thawed according to the manufacturer’s instructions by briefly plunging the 
closed straws for 1 minute into water warmed to 30°C, emptying of the 
contents into a petri dish (NUNC, Rochester, USA), and transferring the 
embryos into sequential thawing solutions (SAGE, San Clemente, USA). 
Once thaw was completed, embryos were transferred to culture medium (GTL, 
Vitrolife, Gothenburg, Sweden) for 2 hours to enable the blastocysts to recover 
and re-expand before biopsy. 
Once recovery and blastocyst re-expansion were complete, a small 
portion of the trophectoderm of the embryo was removed with standard 
trophectoderm biopsy techniques (McArthur et al., 2005). Trophectoderm 
samples were washed and placed into a PCR tube (Eppendorf, Hamburg, 
Germany) in a solution of lysis buffer (Reprogenetics, Oxford, UK). 
Blastocysts were immediately refrozen using the Kitazato vitrification 
technique with the Cryotop loading device (Kitazato, Tokyo, Japan). The 
samples were sent to the genetics lab (Reprogenetics, Oxford, UK) to be 
analysed with NGS (Illumina, USA). The analysis revealed 4/8 of the embryos 
were chromosomally normal (Table I). Abnormalities of the other 4 embryos 
appeared to be multiple aneuploidies (Table I). 
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Grade of blastocyst at 
1st slow thaw  
Result of NGS 
Biopsy  
Grade of Embryo 
prior to transfer 
Embryo Outcome 
3Bb 3Bb Euploid 5Ab 1st DET-Biochemical 
Pregnancy 3Bc 3Bc Euploid 4Bb 
3Bb 3Bb Complex 
Aneuploidy 
N/A-discarded - 
3Ab 3Ab Complex 
Aneuploidy 
N/A-discarded - 
4Bb 4Bb Complex 
Aneuploidy 
N/A-discarded - 
4Bb 4Bb Complex 
Aneuploidy 
N/A-discarded - 
4Cb 4Cb Euploid 3Ab  2nd DET, singleton 
live birth 41 weeks 
gestation. 
5Ab 5Ab Euploid 4Bb 
 
The couple was prepared for frozen embryo transfer with oral 
oestrogens (2 mg Progynova, Bayer, Switzerland 4 times a day) from day 2 of 
the menstrual cycle. When the endometrium reached a minimum of 7mm 
thickness and a distinctive triple layer was observed, vaginal progesterone was 
administered (Cyclogest, Actavis, UK 800mg/day).  
Five days after the start of progesterone administration, two 
normoploid blastocysts grade 5Ab and 4Bb (Gardner et al., 2000) were thawed 
by the warming technique (Kitazato). The patient requested a Double Embryo 
Transfer (DET). CREATE Fertility Unit’s policy is to actively encourage 
Single Embryo Transfer (SET) when euploidy is confirmed. The 2 embryos 
survived the warming process and leading to a biochemical pregnancy 9 days 
after transfer, confirmed by serum beta Human Chorionic Gonadotrophin 
(bhCG). However, this pregnancy ended 2 days later, which was diagnosed by 
declining serum beta human Chorionic Gonadotrophin (bhCG) levels. 
The second frozen embryo transfer was prepared using the same 
method, i.e., use of oral oestrogens to prepare the endometrium. Once the 
uterus had reached 7mm and a distinctive triple layer was observed, the luteal 
phase was triggered with progesterone. Five days later, the remaining 2 
euploid blastocysts 3Ab and 4Bb were thawed and transferred. The couple 
achieved a live birth of a 3800g male baby at 41 weeks gestation. 
 
Discussion 
The need to refreeze human embryos has been one of the risks of 
assisted reproduction procedures, for example, if the procedure must be 
abandoned during frozen embryo transfer procedures. With the slow freeze 
technique, the low efficiency of survival after thaw indicates that refreezing is 
an extremely risky procedure and can lead to failure of survival of the embryo 
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after the second thaw process. However, with the introduction of the high 
efficiency cryopreservation procedure of vitrification, the refreezing of human 
embryos has become a distinct possibility. The need to refreeze human 
embryos could become significant with the introduction of NGS as an 
established PGS technique because patients with cryopreserved embryos may 
wish to have PGS, which would require thawing of their embryos, biopsy of 
suitable blastocysts, and refreezing of the biopsied blastocysts prior to analysis 
with NGS. Embryo refreezing permits the field of assisted reproductive 
technology to adopt a strategy that enables NGS on previously cryopreserved 
embryos to allow this powerful technology to be available to all patient groups.  
A few reports have described the procedure of embryo refreezing by 
vitrification (Farhat et al., 2001, Safari et al., 2016). Theoretically vitrification 
and slow freezing both rely on dehydration of human cells and are therefore 
not incompatible, no reports have explored the refreezing by vitrification of 
human blastocysts previously frozen by the slow freeze method. In this report, 
we outline a successful pregnancy after thawing of human blastocysts frozen 
by the slow freeze method, trophectoderm biopsy for PGS with NGS, and 
same day refreezing with vitrification.  
The fact that embryos can tolerate this process and retain their capacity 
for implantation, and establish pregnancy suggests that PGS with NGS can be 
offered to patients with previously cryopreserved embryos even in cases where 
these are cryopreserved with the slow freeze method. 
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